Teeth Without a Bite: Why India’s Medical Ad Law is Failing

Abstract

The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, was enacted to protect public health by prohibiting misleading advertisements for drugs and banning claims of “magical” cures. Decades later, the explosion of digital media, telecommunications, and highly commercialised healthcare networks has exponentially scaled the reach of these prohibited advertisements.

Table of Contents

The Exposition (The Problem)

Despite recent judicial interventions—where Indian courts have strictly penalised misleading claims and reinforced the scope of the Act—the law suffers from severe operational paralysis. Enforcement mechanisms remain functionally inert, allowing illegal, deceptive health advertisements to proliferate across digital and broadcast channels as a “silent menace” that endangers vulnerable consumers.

The Debate (Core Perspectives)

Pro-Regulation / Judicial Activism

Proponents argue that stringent judicial oversight and a severe overhaul of the enforcement machinery are absolutely vital. They contend that the state must aggressively prosecute violators to prevent public exploitation, medical complications, and the erosion of scientific temperament by unchecked misinformation.

Implementation / Industry Realities

Critics and policy analysts counter that the 1954 Act is structurally outdated and ill-equipped for the internet era. They argue that purely punitive, top-down judicial measures fail because the sheer volume of modern digital content outpaces obsolete regulatory bodies, pointing instead to a need for modernised statutory frameworks, multi-agency digital surveillance, and co-regulatory models with tech platforms.

Conclusion

The conflict highlights a critical governance gap: judicial willingness alone cannot substitute for administrative capability. To transform the law from a paper tiger into an effective shield, India must bridge the chasm between strict legal pronouncements and modern, technology-driven enforcement infrastructures.

Drugs and Magic Remedies (Objectionable Advertisements) Act

The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 is an Indian parliamentary law enacted to control the advertising of drugs and prevent self-medication for serious medical conditions through misleading or false claims.

Key Objectives and Prohibitions

The Act strictly prohibits advertisements that:

Promote Specific Conditions: Offer treatments, cures, or mitigation for 54 scheduled/notified diseases and disorders (such as cancer, diabetes, AIDS, blindness, and asthma).
Target Reproductive and Sexual Health: Suggest the procurement of miscarriage, prevention of conception, enhancement of sexual pleasure, or correction of menstrual disorders.
Push “Magic Remedies”: Promote talismans, mantras, charms, or any item claiming miraculous or supernatural powers to diagnose, cure, or mitigate diseases.
Make False Claims: Present a drug with a false impression or misleading character regarding its true efficacy.
Cross Borders: Involve the import or export of any document containing a prohibited advertisement.

Exemptions Under the Act

The law allows specific, verified forms of communication, including:

Signboards or notices placed by registered medical practitioners on their premises.
Bona fide scientific or social treatises and academic journals.
Confidential communications or circulars sent strictly to registered medical practitioners.
Official publications made or authorised by the government.

Penalties and Enforcement

The Act provides for penalties and enforcement measures against prohibited advertisements.

Category	Provisions
Offence Type	Violations are classified as cognisable offences, allowing empowered gazetted officers to conduct searches, seizures, and forfeitures.
First Conviction	Punishable by imprisonment for up to 6 months, a fine, or both.
Subsequent Convictions	Punishable by imprisonment for up to 1 year, a fine, or both.
Corporate Liability	Companies and responsible officers face prosecution unless they prove the offence occurred without their knowledge or that they exercised due diligence.

Case Laws on Drugs and Magic Remedies Act

Judicial interpretation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, has shaped commercial free speech, consumer protection, and strict regulatory enforcement in India.

The major landmark judgements, constitutional tests, and recent judicial directives define the enforcement of this Act:

1. The Constitutional Benchmark

Hamdard Dawakhana v. Union of India (AIR 1960 SC 554)

The Issue: The constitutional validity of the Act was challenged on the grounds that it violated the Right to Freedom of Speech and Expression (Article 19(1)(a)) and the Right to Carry on Trade and Business (Article 19(1)(g)).
The Ruling: The Supreme Court upheld the validity of the Act. The Court famously ruled that commercial advertisements do not enjoy the absolute protection of free speech under Article 19(1)(a) if they deal with trade or business. The Court noted that advertising an illegal or prohibited drug to promote self-medication for serious illnesses does not serve the public interest, and the legislature has full authority to curb elements causing societal harm. However, the court did strike down a portion of Section 8 (the power to seize documents) as unconstitutionally vague, which was subsequently amended.

2. Mandatory State Enforcement and Grievance Redressal

Indian Medical Association v. Union of India & Ors. (Supreme Court Judgement, March 26, 2025)

The Issue: A public interest petition highlighted a systemic failure by states to curb false advertisements, alongside non-compliance from prominent figures making deceptive claims.
The Ruling: A two-judge bench observed that while the Act is seven decades old, it has suffered from poor implementation. The Supreme Court directed all state governments and union territories to appoint dedicated gazetted officers authorised to conduct searches and seizures under Section 8 of the Act. Furthermore, the court mandated states to set up accessible citizen grievance redressal mechanisms to directly register and act on complaints regarding misleading health advertisements.

3. Evidentiary Burden and Scope of Text

K.S. Saini & Anr. vs Union Of India (Delhi HC, 1966)

The Issue: Criminal prosecution was launched under Section 7 against a clinic distributing pamphlets advertising modern scientific treatments and electronic therapies alongside generic terms.
The Ruling: The High Court quashed the criminal prosecution. The court established that for an advertisement to be penalised under Section 3(b) or 3(d), the text must explicitly and clearly suggest that a specific drug is recommended for a prohibited condition. Vague references to clinical or scientific practices do not automatically attract criminal liability under the Act unless a direct nexus to a prohibited claim is proven.

4. Direct Conviction for Aphrodisiac Claims

Kunnath Pharmaceuticals v. State of Kerala (Ernakulam Court, 2023)

The Issue: The Department of Ayurveda Drugs Control prosecuted a company for advertising a natural capsule called “Musli Power Extra” with claims targeting sexual enhancement, an explicit violation of Section 3 of the Act.
The Ruling: Highlighting corporate accountability under Section 9, the trial court found the managing director guilty. The court handed down a four-month imprisonment sentence and a financial penalty, demonstrating that traditional patent/proprietary systems (like Ayurveda) are equally bound by the statutory restrictions of the DMR Act.

5. Overlapping Media Codes

Paras Gupta v. Union Of India (Jammu & Kashmir HC, 2015)

The Issue: Broadcasters and alternative health channels were airing round-the-clock infomercials promoting talismans, rings, and mantras claiming miraculous physical cures.
The Ruling: The Court emphasised that broadcasting bodies and self-regulatory councils (like ASCI) must read the Cable Television Networks Rules alongside the DMR Act. Media platforms cannot escape liability by claiming they are mere intermediaries if they systematically monetise content that fosters superstition or sells explicit “magic remedies” prohibited under Section 5.

Dr S G Kabra’s Case Before Rajasthan High Court

The case of Dr S.G. Kabra v. State of Rajasthan (S.B. Civil Writ Petition No. 1135/1989) is a foundational Public Interest Litigation (PIL) that significantly tightened the systemic enforcement of the Act.

The Core Issue

Dr S.G. Kabra, a prominent medical professional and researcher (then serving as the Director of Research at the Santokba Durlabhji Memorial Hospital in Jaipur), approached the Rajasthan High Court to highlight systemic failures in implementing the Act. He brought to the court’s attention a vast number of highly objectionable advertisements routinely published in major newspapers and popular magazines. These advertisements openly promised absolute cures for chronic and incurable conditions, aggressively pushed superstitious “magic remedies”, and fostered dangerous self-medication habits among the public.

Dr Kabra argued that despite explicit statutory prohibitions built into the 1954 Act, state authorities were entirely passive, leaving consumers vulnerable to exploitation.

The Rajasthan High Court’s Directive

Decided on September 22, 1989, by Justice Surendra Nath Bhargava, the court expressed sharp disapproval regarding the proliferation of unregulated medical claims in print media.

Because the primary obstacle was a lack of a dedicated monitoring network, the High Court directed the Director General of Police (DGP) and Inspector General of Police (IGP) of Rajasthan to establish a Special Cell. The strict function of this dedicated cell was to:

Maintain a continuous vigil over newspapers, periodicals, and magazines circulating within the state.
Directly track, identify, and clamp down on any publications or advertisers acting in clear violation of the Act.

The Impact and Enforcement Legacy

Following the High Court’s order, a Special Cell was officially created under the Crime Investigation Department (CID-CB) of Rajasthan.

This cell was organized under the direct supervision of the Superintendent of Police (SP-I, CID-CB) and staffed with dedicated Inspectors and Sub-Inspectors explicitly tasked with scanning local media and executing search-and-seizure operations against fraudulent advertisers. In subsequent years, this case has repeatedly been cited in other Indian High Courts (such as in Kishore Verma v. Govt. of India) as the leading precedent establishing that state governments cannot merely rely on passive complaint filing; they must maintain active, state-funded law enforcement units to protect public health from deceptive medical advertising.

Subsequent Cases Built Upon This Policing Mechanism

The proactive enforcement mechanism established in Dr. S.G. Kabra v. State of Rajasthan—moving away from passive complaint-based enforcement to state-mandated, institutional policing units—has served as a vital blueprint for several subsequent judicial interventions in India.

Over the decades, multiple High Courts and the Supreme Court have adapted and expanded this exact policing model to counter evolving forms of media, such as satellite television and digital internet ads.

Subsequent major legal milestones directly built upon or replicated this active policing framework:

1. Clamping Down on TV Telecasts (Bombay High Court)

The Precedent Extension: Evangelist Sanal Edamaruku v. State of Maharashtra & Ors. (Bombay High Court, Aurangabad Bench).
The Application: Recognizing that deceptive “magic remedies” and objectionable advertisements had transitioned from print media to around-the-clock satellite television infomercials, a division bench comprising Justices T.V. Nalvade and M.G. Sewlikar built directly on the Kabra logic.
The Policing Mechanism: The High Court explicitly directed the Maharashtra State Government to create a dedicated state-level Special Cell. The explicit mandate of this new police unit was to monitor satellite channels continuously, identify broadcasters and advertisers violating the Drugs and Magic Remedies (DMR) Act, and automatically register criminal FIRs without waiting for private consumer complaints.

2. Digital Scanning and Media Regulatory Alliances

The Precedent Extension: Kishore Verma & Anr. v. Union of India & Ors.
The Application: This case addressed the massive regulatory loophole involving online advertisements, e-commerce spaces, and cross-border digital platforms.
The Policing Mechanism: The court noted that physical state border policing units (like Rajasthan’s CID-CB Cell) needed digital upgrades. The court mandated the institutional integration of Cyber Crime Cells into the enforcement of the DMR Act. Under this system, state cyber policing units were directed to cooperate with the Advertising Standards Council of India (ASCI) to systematically track social media handles, websites, and algorithmic online marketplaces pushing banned cures.

3. The Ultimate Structural Mandate (Supreme Court of India)

The Precedent Extension: Indian Medical Association v. Union of India & Ors. (Supreme Court of India)
The Application: While previous cases like Dr. S.G. Kabra were limited to their respective states (Rajasthan, Maharashtra), the Supreme Court observed a nationwide, systemic failure by state machineries to enforce the 70-year-old law against prominent commercial entities.
The Policing Mechanism: Elevating the Kabra framework to a mandatory pan-India level, a two-judge bench ordered all State Governments and Union Territories across India to formally appoint dedicated Gazetted Officers under Section 8 of the Act. The Court mandated that these offices cannot exist purely on paper; they must be actively empowered, publicly accessible, and backed by localized policing units to perform immediate search, seizure, and criminal prosecution against deceptive medical marketing.

How the Policing Model Has Changed

The table below illustrates how courts have scaled the initial Dr. S.G. Kabra print-media policing model to match modern requirements:

Era / Precedent	Primary Media Target	Policing Body Responsible	Enforcement Trigger
Dr. S.G. Kabra (1989)	Local Print & Newspapers	State CID-CB Special Cell	Active scanning of physical print media.
Bombay HC (TV Era)	Satellite TV & Infomercials	State-Level Television Monitoring Cells	Live logging of broadcast channels.
Modern High Court / ASCI Cases	E-commerce & Social Media	Cyber Crime Units + Self-Regulatory Councils	Direct URL tracking and digital takedown notices.
Supreme Court Directive	Cross-Platform / Corporate	Nodal Gazetted Officers + Local Police	Citizen grievance systems paired with spot searches.

Following the landmark ruling in Dr. S.G. Kabra v. State of Rajasthan (1989), the Rajasthan High Court recognized that the primary hurdle in stopping illegal medical advertisements was the lack of an active enforcement body. To fix this, the court ordered the creation of a Special Cell within the Crime Investigation Department (Crime Branch) — commonly known as the CID-CB.

Headed by the Superintendent of Police (SP-I, CID-CB) and staffed by dedicated police inspectors, the CID Special Cell was given clear, proactive legal responsibilities to actively clean up the media landscape:

CID Special Cell: Enforcement Responsibilities

1. Continuous Media Scanning and Vigilance

Proactive Monitoring: Rather than waiting for a consumer or rival brand to file a formal complaint, the cell is legally mandated to maintain a continuous vigil over all media platforms circulating within the state.
Material Inspected: Inspectors systematically scan daily regional and national newspapers, weekly periodicals, health magazines, pamphlets, and local flyers distributed in Rajasthan.

2. Identifying Statutory Violations

Disease Cross-Checking: The cell tracks down ads that claim to cure, prevent, or mitigate any of the 54 chronic diseases listed in the Schedule to the Act (such as diabetes, blindness, cancer, and high blood pressure).
Supernatural & Magic Claims: They isolate advertisements offering talismans, mantras, charms, or kavachas that claim miraculous healing powers.
Prohibited Health Targets: The cell is responsible for flagging advertisements dealing with sexual performance enhancers, miscarriage procurement, and contraception.

3. Immediate Search and Seizure Operations

Section 8 Powers: Empowered under Section 8 of the Act, officers of the cell can carry out spot searches at printing presses, corporate offices, distribution agencies, and clinics publishing these advertisements.
Forfeiture: They are authorized to seize any documents, layout copies, flyers, or actual stocks of the advertised “magic remedies” to be used as primary evidence in a court of law.

4. Direct Registration of Criminal Cases (FIRs)

Cognizable Enforcement: Because violations of the Act are cognizable offenses, the cell can directly register a First Information Report (FIR) under Section 7 against the accused parties without requiring a prior judicial warrant.
Targeting the Entire Chain: The cell holds the legal responsibility to prosecute the entire supply chain of the advertisement. This includes:
- The Advertiser (the quack, doctor, or company selling the product).
- The Publisher/Printer (the newspaper management or press printing the text).
- The Agency (the media house that conceptualized and placed the ad).

5. Inter-Departmental Coordination

Drug Control Alliance: The CID Cell operates as the enforcement arm for the state’s Drug Control Organization. While drug inspectors provide the technical expertise on whether a substance qualifies as a misbranded drug, the CID Cell provides the policing infrastructure required to conduct raids and handle criminal arrests.

A rigorous legal analysis, to examine the specific statutory intersections, systemic loopholes, and defense strategies that emerged from the creation of the CID Special Cell.

The Core Statutory Conflict: Police vs. Drug Inspectors

A primary area for academic analysis is the jurisdiction clash between two distinct enforcement machineries:

The Code of Criminal Procedure (CrPC) / Bharatiya Nagarik Suraksha Sanhita (BNSS): Under Section 7 of the DMR Act, offenses are cognizable, giving the CID Special Cell the power to arrest and investigate without a magistrate’s warrant.
The Drugs and Cosmetics Act, 1940: This law generally empowers specialized Drug Inspectors to prosecute misbranded substances.

Research Insight: The Hybrid Enforcement Model

The Dr. S.G. Kabra ruling effectively decided that because misleading advertisements are public health harms embedded in mass media, standard drug inspectors lacked the infrastructure to police printing presses and media houses. By introducing the CID-CB, the court established a hybrid enforcement model—where the police handle the media crackdown and seizure, while the Drug Control Department provides the technical chemical/medical verification for the trial.

Corporate Liabilities & The “Due Diligence” Defense

When the CID Special Cell targets a violation, it invokes Section 9 of the DMR Act (Offenses by Companies).

Vicarious Liability: Every person who, at the time the offense was committed, was in charge of and responsible to the company for the conduct of its business is deemed guilty.
The Statutory Defense: A corporate director or publisher can only escape liability if they prove two strict criteria simultaneously:
1. The offense was committed without their knowledge.
2. They exercised all due diligence to prevent the commission of such an offense.

Research Insight: Publisher Due Diligence

In the decades following the Kabra case, courts have set an incredibly high bar for what constitutes “due diligence” for publishers. Relying on a signed indemnity bond from an advertiser (e.g., “The advertiser takes full responsibility for the content of this ad”) is not accepted by courts as due diligence. The publisher is legally expected to cross-check the advertisement copy against the 54 prohibited diseases in the DMR Schedule before printing it.

The Modern Loophole: The Intermediary Liability Dilemma

The Digital Era

Today, misleading advertisements are delivered via programmatic algorithms on social media platforms or international e-commerce sites.

Research Insight: Intermediary Safe Harbor Protection

Under Section 79 of the IT Act, digital platforms claim “Intermediary Safe Harbor protection,” arguing they are merely passive conduits for third-party advertisements. However, drawing from the Kabra doctrine and the recent Indian Medical Association (2024–2025) Supreme Court directives, legal scholars argue that when a platform profits from targeted, algorithmic delivery of a health ad, it ceases to be a passive intermediary. It assumes the role of a modern “publisher” and falls under the active enforcement gaze of the state’s Cyber Crime and CID cells.

The Exposition (The Landmark Ruling)

The operational paralysis of the Act was starkly highlighted during the landmark Supreme Court proceedings in Indian Medical Association v. Patanjali. Led by Justices Hima Kohli and Ahsanuddin Amanullah, the Court reprimanded the Union and State governments for regulatory inaction. Despite formal legal commitments made to the Court in November 2023, Patanjali continued to air advertisements promising “permanent relief” for chronic disorders explicitly protected under the 1954 Act’s schedules (such as diabetes, obesity, and asthma). The Court issued stringent contempt notices, eventually extracting mandatory national newspaper public apologies from the founders. The case exposed how deeply embedded corporate interests could manipulate the public sphere.

The Debate (Core Perspectives)

1. Pro-Regulation / Judicial Activism

Proponents argue that the Supreme Court’s aggressive intervention was a necessary corrective measure to protect vulnerable consumers. They point out that judicial pressure successfully forced a systemic expansion—expanding the scope to mandate self-declaration advertising forms for all media broadcasters and holding social media influencers legally liable for false endorsements. From this viewpoint, judicial force is the only mechanism strong enough to awaken an inert bureaucracy.

2. Implementation / Institutional Realities

Critics and policy analysts counter that the Patanjali case perfectly illustrates the limits of judicial oversight. While the Court successfully extracts symbolic apologies, it cannot act as a permanent, systemic regulator. They note that even as the Court reprimanded the state, policy volatility persisted—such as the legal flip-flopping and eventual withdrawal of Rule 170 of the Drugs and Cosmetics Rules, which sought to mandate state licensing clearance before advertising traditional medicines. This side argues that until the structural and digital surveillance gaps in the executive machinery are resolved, judicial mandates remain temporary band-aids.

Conclusion: The Need for Modernised Enforcement

The Patanjali ruling serves as a vital case study: judicial willingness cannot indefinitely compensate for institutional failure. While the Supreme Court successfully asserted the rule of law over a powerful commercial enterprise, the long-term solution requires a modernised administrative framework capable of proactively policing digital health spaces.

Written By: Dr.Shri Gopal Kabra – MBBS,LLB, MSc, MS(Anatomy), MS(Surgery)
Director Clinical Services; Bhagwan Mahaveer Cancer Hospital, Jaipur-302017
Email: [email protected], Ph no: 8003516198

What's Hot

Tags

Categories